International Stem Cell Corp. (QB)
Ticker Symbol: USOTC:ISCO
OTC Market Tier: OTCQX U.S.
CIK Number: 0001355790
Security Type: Common Stock
ISCO Address: 5950 Priestly Drive
Carlsbad, California 92008
ISCO Country: USA
ISCO Phone: (760) 940-6383
ISCO Fax #: (760) 476-0600
Description: International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial backgrounds, with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell?. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (, and stem cell-based skin care products through its subsidiary Lifeline Skin Care (
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 720,000,000
Shares Outstanding: 7,533,083
Shares Outstanding Date: 10/08/2019
Shares Holder Count: 633
Shares Holder Date: 04/15/2019
Market Capitalization: $ 4,143,195.65
Key Executives: Denise Boyajian - Manager, Ops.
Denise Boyajian - Manager, Ops.
Investor Relations - IR
Investor Relations - IR
Russell Kern - EVP
Russell Kern - EVP
Andrey Semechkin - CEO
Andrey Semechkin - CEO
Paul Maier - Dir.
Paul Maier - Dir.
Donald Wright - Co-Chairman
Donald Wright - Co-Chairman
Sophia Garnette - VP, Legal
Sophia Garnette - VP, Legal
Number of Employees: 45
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 2005
Auditor: BDO USA, LLP
Auditor Address: 50 West San Fernando St.
Suite 200
San Jose, CA 95113
United States
Auditor Website: N/A
IR Firm: N/A
Legal Counsel: DLA Piper
Legal Counsel Address: 2000 University Avenue
San Diego, CA 94303-2214
Legal Counsel Website:
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Securities Transfer Corporation
TA Address: 2901 Dallas Parkway
Suite 380
Plano, TX 75093
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 56,110
Short Date: 09/13/2019
Closing MMID: 9
BFCMmid: 7
Tier ID: 2
Status: Active

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.